Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-07

Clinical Trial Update: The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel

View source ↗

Summary

This clinical trial update notes that the Ambrosia-related study in Israel addressing allergic rhinitis and asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Meir Medical Center | Conditions: Allergic Rhinitis, Asthma | Status: COMPLETED